MAAT INDEX

CLAIM #23056 · EMR (EMR) · 2026Q2 earnings call · May 5, 2026 · due Sep 30, 2026

From an ACV perspective, yes, we continue to reiterate the 10% plus for the full year.

Michael Baughman · CFO

PENDING
graded after results covering Sep 30, 2026 are reported

How to check this claim

Look at: Annual contract value (ACV) growth rate, full fiscal year

It came true if: ACV growth >= 10%

Where: management commentary / company earnings materials (full-year results, Q4 call or 10-K)

In context

rd, and it all nets out. We feel very comfortable holding the 28% for the year. Julian Mitchell: That is helpful. Thank you. And then as we are looking at the balance of the year, I think you have in Q3 and Q4 a mid-single-digit sequential revenue increase dialed in and kind of high-30s operating leverage. Is that a fair placeholder for both quarters? Anything we should bear in mind in one versus the other? And on the ACV front, I think you are embedding an acceleration in the back half. Anything to call out there? Michael J. Baughman: I think from a leverage perspective, the numbers are affected by that software contract renewal dynamic and the effects there. But if you take that out, we will be over 40% leverage on the full year, which certainly means some acceleration in the back half. From an ACV perspective, yes, we continue to reiterate the 10% plus for the full year. We had a good quarter, and we continue to think that the ACV growth of 10% plus is the right number for us. And I think you said sequential growth mid-single digits. That is correct. And also year-over-year growth is mid-single digits. So I think that is an important addition to your statement. Sequential growth mid-single digit is consistent with year-over-year mid-single digit, and if you do the math, the leverage will be a tad better than the 30s you stated for the second half. Yeah. Operator: Our next question is from Jeffrey Todd Sprague with Vertical Research. Jeffrey Todd Sprague: Hey, thank you. Good morning, everyone. Just wanted to get a broader sense of the total global ramifications of this. The nature of my question, right, is the comment of the war stays contained in the Mid

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q2 earnings call.